Ophthalmic Research and Drug Delivery

Advances in ophthalmic drug delivery systems, for example, Punctal Plugs, Ocular Therapeutix, Mati therapeutics and gel-shaping drops can be breakthrough in ophthalmic research and propel tranquilize conveyance framework to maximize the therapeutic effect of a particular drug. Topical mix of corticosteroid and against infective specialists, Drugs used in the treatment of allergic conjunctivitis, Oral and topical nonsteroidal anti inflamatory agents (NSAIDs) and Retinoblastoma chemotherapy are few created plan to treat ophthalmic sicknesses. Organizations like Allergan, Pfizer, Bausch + Lomb, Merck and Co. also, Regeneron are effectively taken an interest in ophthalmic research and medication advancement. As indicated by visiongain (Ophthalmic Drugs: World Market Prospects - 2013-2023; October 2013), the overall ophthalmic market was $17.5 billion in 2011 and is relied upon to develop to $34.7 billion by 2023, speaking to a 5.9% intensified yearly development rate.

  • Transplantation advancements for retina
  • Drugs utilized as a part of the treatment of unfavorably susceptible conjunctivitis
  • Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs)
  • Diagnostic colour arrangements
  • Ocular and systemic reactions of medications
  • IVT infusion saving methodologies
  • Extended movement approaches

Related Conference of Ophthalmic Research and Drug Delivery

September 16-17, 2025

20th International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
September 22-23, 2025

8th International Eye and Vision Congress

Amsterdam, Netherlands
October 20-21, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
November 03-04, 2025

39th European Ophthalmology Congress

Rome, Italy
April 20-21, 2026

3rd International Conference on Ophthalmology

Barcelona, Spain

Ophthalmic Research and Drug Delivery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in